We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Antitrust Compliance and Clinical Integration: Assessing Anti-Competitiveness of Collaborations, Minimizing Risk of Agency Challenges

20 June 2017

Leigh Oliver and Robert Leibenluft are providing healthcare counsel with an examination of the latest developments with respect to clinical integrations programs, as well as the FTC and DOJ assessment processes during this live webinar.

The webinar's panel is describing how the FTC investigates collaborations among providers such as Accountable Care Organizations (ACOs) and clinically integrated networks. They are discussing collaborative activities that are unlikely to raise antitrust concerns, and the types of situations that are likely to prompt an investigation. They are addressing how to reduce antitrust risks in forming and operating a physician network, joint venture or ACO, and how best to respond to an antitrust investigation if one occurs.

From Hogan Lovells

Loading data